Predictive Oncology Inc.

NasdaqCM:POAI Stock Report

Market Cap: US$5.3m

Predictive Oncology Management

Management criteria checks 4/4

Predictive Oncology's CEO is Raymond Vennare, appointed in Nov 2022, has a tenure of 3.17 years. total yearly compensation is $525.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $5.70K. The average tenure of the management team and the board of directors is 2 years and 3.8 years respectively.

Key information

Raymond Vennare

Chief executive officer

US$525.0k

Total compensation

CEO salary percentage100.0%
CEO tenure2yrs
CEO ownership0.1%
Management average tenure2yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Here's Why We're Watching Predictive Oncology's (NASDAQ:POAI) Cash Burn Situation

Jun 29
Here's Why We're Watching Predictive Oncology's (NASDAQ:POAI) Cash Burn Situation

Predictive Oncology has a new CEO

Oct 20

Predictive Oncology announces retirement of CEO Mel Engle

Sep 16

Predictive Oncology regains Nasdaq compliance

Feb 02

CEO Compensation Analysis

How has Raymond Vennare's remuneration changed compared to Predictive Oncology's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$14m

Jun 30 2024n/an/a

-US$14m

Mar 31 2024n/an/a

-US$15m

Dec 31 2023US$525kUS$525k

-US$14m

Sep 30 2023n/an/a

-US$17m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$639kUS$88k

-US$26m

Sep 30 2022n/an/a

-US$26m

Jun 30 2022n/an/a

-US$27m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$33kn/a

-US$20m

Compensation vs Market: Raymond's total compensation ($USD525.00K) is about average for companies of similar size in the US market ($USD646.00K).

Compensation vs Earnings: Raymond's compensation has been consistent with company performance over the past year.

CEO

Raymond Vennare (71 yo)

2yrs

Tenure

US$525,000

Compensation

Mr. Raymond F. Vennare is Chief Executive Officer and Chairman at Predictive Oncology Inc. from November 01, 2022. He Co-Founded ThermalTherapeutic Systems, Inc. in 2006 and served as its Executive Vice Pr...

Leadership Team

NamePositionTenureCompensationOwnership
Raymond Vennare
CEO & Chairman2yrsUS$525.00k0.11%
$ 5.7k
Joshua Blacher
Interim Chief Financial Officer1.2yrsno datano data
Theresa Ferguson
Senior Director of Marketing2.6yrsno datano data
Lawrence DeLucas
Senior Vice President of Biologicsno datano datano data
Arlette Uihlein
Senior VP of Translational Medicine & Drug Discovery and Medical Directorno datano datano data

2.0yrs

Average Tenure

Experienced Management: POAI's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Raymond Vennare
CEO & Chairman3.2yrsUS$525.00k0.11%
$ 5.7k
Bernard Harris
Member of Business Advisory Board1.4yrsno datano data
Charles Nuzum
Lead Independent Director4.3yrsUS$98.90kno data
Andrew Einhorn
Member of Business Advisory Board1.4yrsno datano data
Veena Rao-Mirmira
Independent Director1.5yrsUS$73.34k0.14%
$ 7.3k
Marc Malandro
Member of Scientific Advisory Board6.2yrsno datano data
Daniel Handley
Independent Director4.8yrsUS$54.45k0.28%
$ 14.9k
Robert Murphy
Member of Scientific Advisory Board6.2yrsno datano data
Matthew Hawryluk
Independent Director2yrsUS$65.56k0.14%
$ 7.6k
Nancy Chung-Welch
Independent Director4.3yrsUS$76.67k0.32%
$ 17.0k
Gregory St. Clair
Independent Director4.3yrsUS$65.56k0.34%
$ 18.0k
Christoph Reinhard
Member of Scientific Advisory Board1.6yrsno datano data

3.8yrs

Average Tenure

64yo

Average Age

Experienced Board: POAI's board of directors are considered experienced (3.8 years average tenure).